The third quarter finished with the year's best first-day pop as Nutanix spiked 131% on Friday. September ended as the most active month of 2016 both in terms of IPO pricings (16) and initial filings (18). Nutanix's incredible first-day performance was a...read more
Tabula Rasa HealthCare, which provides e-prescription fulfillment and medication risk management services, raised $52 million by offering 4.3 million shares at $12, below the range of $13 to $15. Tabula Rasa HealthCare plans to list on the Nasdaq under the...read more
Five IPOs are scheduled to close out the third quarter, putting September on pace to be the year's most active month for IPOs. Nutanix's highly-anticipated IPO will get the most attention, given its growth, scale, and implications for the...read more
Tabula Rasa HealthCare, which provides risk management solutions to reduce adverse drug events (ADEs) at long-term care facilities, announced terms for its IPO on Monday. The Moorestown, NJ-based company plans to raise $60 million by offering 4.3 million...read more
US IPO Weekly Recap: Nutanix skyrockets 131% in year's best IPO debut
The third quarter finished with the year's best first-day pop as Nutanix spiked 131% on Friday. September ended as the most active month of 2016 both in terms of IPO pricings (16) and initial filings (18). Nutanix's incredible first-day performance was a...read more
Behind the PACE: Tabula Rasa HealthCare prices IPO at $12, below the range
Tabula Rasa HealthCare, which provides e-prescription fulfillment and medication risk management services, raised $52 million by offering 4.3 million shares at $12, below the range of $13 to $15. Tabula Rasa HealthCare plans to list on the Nasdaq under the...read more
US IPO Week Ahead: Year's largest US tech company to IPO, Nutanix, leads 5-deal week
Five IPOs are scheduled to close out the third quarter, putting September on pace to be the year's most active month for IPOs. Nutanix's highly-anticipated IPO will get the most attention, given its growth, scale, and implications for the...read more
ADEs prevention for seniors: Tabula Rasa HealthCare sets terms for $60 million IPO
Tabula Rasa HealthCare, which provides risk management solutions to reduce adverse drug events (ADEs) at long-term care facilities, announced terms for its IPO on Monday. The Moorestown, NJ-based company plans to raise $60 million by offering 4.3 million...read more